Dynasil (DYSL) – Management Comments
-
Dynasil (DYSL) Subsidiary Secures Four Phase I Technology Development Grants by U.S. DOE
-
Dynasil (DYSL) Reports Submission of Xcede Technologies' Application for First-in-Human Clinical Trial
-
-
-
-
-
-
Back to DYSL Stock Lookup